FR2265406A1 - Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins - Google Patents
Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulinsInfo
- Publication number
- FR2265406A1 FR2265406A1 FR7509251A FR7509251A FR2265406A1 FR 2265406 A1 FR2265406 A1 FR 2265406A1 FR 7509251 A FR7509251 A FR 7509251A FR 7509251 A FR7509251 A FR 7509251A FR 2265406 A1 FR2265406 A1 FR 2265406A1
- Authority
- FR
- France
- Prior art keywords
- hepatitis
- vaccine
- globulins
- alumin
- australian type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 208000002672 hepatitis B Diseases 0.000 title abstract 2
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title abstract 2
- 229940124736 hepatitis-B vaccine Drugs 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title abstract 2
- 102000006395 Globulins Human genes 0.000 title 1
- 108010044091 Globulins Proteins 0.000 title 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 title 1
- 210000002966 serum Anatomy 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108010068307 Alpha-Globulins Proteins 0.000 abstract 1
- 108010087504 Beta-Globulins Proteins 0.000 abstract 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 abstract 1
- 108010074605 gamma-Globulins Proteins 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 229960000380 propiolactone Drugs 0.000 abstract 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2415604A DE2415604A1 (de) | 1974-03-30 | 1974-03-30 | Impfstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2265406A1 true FR2265406A1 (en) | 1975-10-24 |
Family
ID=5911758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7509251A Pending FR2265406A1 (en) | 1974-03-30 | 1975-03-25 | Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE827145A (xx) |
DE (1) | DE2415604A1 (xx) |
DK (1) | DK110575A (xx) |
FR (1) | FR2265406A1 (xx) |
LU (1) | LU71976A1 (xx) |
NL (1) | NL7502660A (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130039943A1 (en) * | 2010-05-03 | 2013-02-14 | Bruno Rene Andre | Novel method |
-
1974
- 1974-03-30 DE DE2415604A patent/DE2415604A1/de active Pending
-
1975
- 1975-03-06 LU LU71976A patent/LU71976A1/xx unknown
- 1975-03-06 NL NL7502660A patent/NL7502660A/xx unknown
- 1975-03-18 DK DK110575A patent/DK110575A/da unknown
- 1975-03-25 BE BE154732A patent/BE827145A/xx unknown
- 1975-03-25 FR FR7509251A patent/FR2265406A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
BE827145A (fr) | 1975-07-16 |
DK110575A (xx) | 1975-10-01 |
NL7502660A (nl) | 1975-10-02 |
DE2415604A1 (de) | 1975-10-02 |
LU71976A1 (xx) | 1975-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2118963T3 (es) | Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos. | |
Resti et al. | Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? | |
DE3268361D1 (en) | New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process | |
HUT38841A (en) | Process for producing compositions for producing immune-response against tumours and virus | |
ES520915A0 (es) | Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular. | |
FR2265406A1 (en) | Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins | |
GB960850A (en) | Measles virus vaccine | |
ATE115863T1 (de) | Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen. | |
JPS6456621A (en) | Aluminum hydroxide gel-added hepatitis b vaccine and preparation | |
EP0339668A3 (en) | Hepatitis a virus antigen | |
ATE18007T1 (de) | Hepatitisimpfstoff. | |
Tong | Hepatitis B vaccination of neonates and children | |
ES357848A1 (es) | Procedimiento mejorado para la preparacion de una vacuna contra la poliomielitis. | |
ATE3058T1 (de) | Herpes-virus-impfstoff und seine herstellung. | |
FURUHATA et al. | A family study of the so-called blood group chimera | |
DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
JPS6477893A (en) | Far infrared radiation heater lamp | |
Stephan | Hepatitis‐Free Reagents in Tests for Australia Antigen | |
JPS57156559A (en) | Measuring method for neutralization antibody | |
NO864382D0 (no) | Midler for forbedring av proteinabsorpsjon. | |
GB1518582A (en) | Viral hepatitis vaccine | |
Felfe et al. | Trends in production of foot-and-mouth disease vaccine. | |
Stuart-Harris | The mechanisms of immunity to influenza virus infection | |
FR2287912A1 (fr) | Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique | |
GB949399A (en) | Poliomyelitis vaccines |